Evidence map›Paper›PMID 15862133›Full record

ReviewCardiovascular diabetology2005

Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice.

Jeanette Schultz Johansen, Alex K Harris, David J Rychly, Adviye Ergul

Registry-linked trialAbstract readReview
In one paragraph

Review in Cardiovascular diabetology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03341117 (Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System), which is not on this map. Cited by 282 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
282citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03341117 phase3completednot on this mapstarted 2014, after this paper: background citation

Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System

TypeinterventionalSponsorCentro Universitario de Ciencias de la Salud, MexicoRan2014 to 2016Enrolled21ConditionsDiabetes Mellitus, Type 2, Antioxidant Enzyme SystemArmsAcetylsalicylic acid, Calcined magnesia
3 · Its place in the literature

Who cites it

282 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

222 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeanette Schultz JohansenUniversity of Tromso, Tromso, Norway. jeajoh@student.uit.no
Alex K Harris
David J Rychly
Adviye Ergul

Funding

Mechanism of Endothelial Dysfunction in DiabetesR15HL076236 · NHLBI · UNIVERSITY OF GEORGIA (UGA) · PI ERGUL, ADVIYE · 2004 to 2004
$188k
NHLBI NIH HHS HL076236-01NHLBI NIH HHS R15 HL076236
6 · The paper itself

Abstract

Cardiovascular complications, characterized by endothelial dysfunction and accelerated atherosclerosis, are the leading cause of morbidity and mortality associated with diabetes. There is growing evidence that excess generation of highly reactive free radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates the development and progression of diabetes and its complications. Overproduction and/or insufficient removal of these free radicals result in vascular dysfunction, damage to cellular proteins, membrane lipids and nucleic acids. Despite overwhelming evidence on the damaging consequences of oxidative stress and its role in experimental diabetes, large scale clinical trials with classic antioxidants failed to demonstrate any benefit for diabetic patients. As our understanding of the mechanisms of free radical generation evolves, it is becoming clear that rather than merely scavenging reactive radicals, a more comprehensive approach aimed at preventing the generation of these reactive species as well as scavenging may prove more beneficial. Therefore, new strategies with classic as well as new antioxidants should be implemented in the treatment of diabetes.

Indexed as

Oxidative StressAnimalsAntioxidantsCardiovascular DiseasesClinical Trials as TopicDiabetes ComplicationsDiabetes MellitusDiabetes Mellitus, ExperimentalDisease ProgressionEndothelium, VascularFree RadicalsHumansHyperglycemiaPractice Guidelines as TopicReactive Oxygen SpeciesRisk Reduction BehaviorAntioxidantsFree RadicalsReactive Oxygen Species

Identifiers

PMID15862133
PMCPMC1131912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.